Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour On, Spot On, Collars, Ear Tags), Animal (Dogs, Cats, Cattle, Pigs, Sheep & Goats) – Global Forecast to 2018

Publisher Name :
Date:1-May-2014
No. of pages: 306

The veterinary pharmaceuticals including parasiticides have transformed the health of companion and livestock animals across the globe in the past two decades. Today, the spectrum of parasiticides for the veterinary applications continues to expand with variety of ectoparasiticides, endoparasiticides, and endectocides being launched every year. The innovations are leading to emergence of novel parasiticide delivery systems as well. Protection of animals from parasitic infestations has also gained greater importance in animal parasiticides market over the years.

In this report, the global animal parasiticides market is broadly segmented by product type, animal type, and geography. By product type, the animal parasiticides are classified into three major segments, namely, endoparasiticides, ectoparasiticides, and endectocides. These product segments are further sub-segmented depending on the formulation type. The endoparasiticides are classified into feed additives, injectables, oral liquids, tablets (oral solids), and other. The ectoprasiticides are classified into dips, sprays, pour on/spot on, collar, ear tags and others. On the basis of animals, animal parasiticides market is segmented into two major categories as companion animals and food producing animals. These major animal segments are further subdivided into different animal types. Companion animals include dogs, cats, horses and other companion animals while food producing animals include poultry, pigs, cattle, sheep and goats, and other food producing animals. The market is divided into North America, Europe, Asia-Pacific, and the Rest of World (RoW), based on geography.

Over the past few years, the animal parasiticides market has witnessed a stable growth. The market is expected to grow at a CAGR of 5.4% from 2013 to 2018 to reach $8,464.6 million by 2018. The overall growth in the animal parasiticides market is largely driven by rising concerns regarding zoonotic diseases; an upsurge in the investment from government organizations, non-government agencies, and leading market players; increasing demand for animal protein and animal-based food, especially in the emerging markets in APAC and Latin American region; implementation of animal welfare acts in developed countries; availability of new broad spectrum parasiticides product offerings from leading players; and an upsurge in the adoption of pet animals. However, stringent regulations for registration and approval of animal parasiticides, restrictions on the use of parasiticides in food producing animals, expensive and time consuming R&D activities to develop a new product, restriction on the use of specific parasiticides in certain countries, emerging species of parasites with resistance to existing parasiticidal agents restrict the growth of the market to a certain extent.

During the forecast period the pour-ons and spot-ons will continue to drive and dominate the animal parasiticides market. A majority share of this growth can be attributed to widening applications of ectoparasiticides for livestock animals. Furthermore, rising demand for pour-ons and spot-ons for companion animals in developed countries is also expected to drive the growth of the animal parasiticides market. Highly organized livestock farms, increased awareness towards prevention of parasitic diseases in livestock animals in order to meet the increased demand for meat and dairy products, and increasing number of farm animals is expected to fuel the demand for pour-ons and spot-ons during the forecast period of 2013-2018.

By 2018, Europe will continue to drive and dominate the animal parasiticides market, followed by North America, RoW, and Asia-Pacific. However, the market share of this region will decrease slightly during 2013 to 2018, primarily due to the increase in demand for parasiticides in the Asia-Pacific and Latin American countries. Majority of the growth in these regions is primarily driven by the increasing demand of preventive measures of parasiticide inestations in the animal health industry in China, India, and Brazil. The growth in the Asia-Pacific and Latin American regions can be attributed to the increased disposable incomes leading to growth in the per capita animal health expenditure in these regions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • •Market Penetration: Comprehensive information on product portfolios offered by the top players in the animal parasiticides market. The report analyzes the animal parasiticides market by product type and by animal type across all geographies
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the animal parasiticides market
  • Market Development: Comprehensive information about the lucrative emerging markets by product, animal, and geography
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the animal parasiticides market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the animal parasiticides market

Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour On, Spot On, Collars, Ear Tags), Animal (Dogs, Cats, Cattle, Pigs, Sheep & Goats) – Global Forecast to 2018

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1Market Size Estimation
1.5.2 Market Crackdown & Data Triangulation
1.5.3 Market Share Estimation
1.5.4 Key Data From Secondary Sources
1.5.5 Key Data Points From Primary Sources
1.5.6 Assumptions

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Key Market Drivers
3.3.1.1 Growing Concerns Regarding Zoonotic Diseases
3.3.1.2 Growing Investment From Government Organizations, Non-Government Agencies, And Leading Market Players
3.3.1.3 Growing Demand For Animal Protein And Animal-Based Food To Drive The Need To Keep Animals Healthy
3.3.1.4 Worldwide Regulations For Prevention Of The Spread Of Animal Diseases
3.3.2 Key Market Restraints
3.3.2.1 Shift To Vegetarian Diet Challenging The Market Growth
3.3.2.2 A Vast Diversity Of Parasites Species
3.3.2.3 Restrictions On The Use Of Endoparasiticides In Food Producing Animals
3.3.2.4 Difficulties In Approval Of Animal Parasiticides
3.3.3 Key Market Opportunities
3.3.3.1 Growing Awareness About Animal Health In Emerging Markets
3.3.3.2 Untapped Market Potential In Rural Areas In Developing Countries
3.3.4 Key Market Trends
3.3.4.1 Growing R&D Investments In The Animal Pharmaceuticals Market
3.3.4.2 Mergers And Acquisitions Among Key Market Players In The Animal Healthcare Market
3.3.4.3 Innovations In Parasiticide Product Offerings To Boost The Market
3.4 Market Share Analysis

4 Global Animal Parasiticides Market, By Product Type
4.1 Introduction
4.2 Endoparasiticide
4.2.1 Feed Additives
4.2.2 Injectables
4.2.3 Oral Liquids
4.2.4 Oral Solids (Tablets, Pills, And Granules)
4.2.5 Other Endoparasiticides
4.3 Ectoparasiticide
4.3.1 Dips
4.3.2 Sprays
4.3.3 Pour-On And Spot-On
4.3.4 Collars
4.3.5 Ear Tags
4.3.6 Others Ectoparasiticides
4.4 Endectocide

5 Global Animal Parasiticides Market, By Type Of Animal
5.1 Introduction
5.2 Companion Animals
5.2.1 Dogs
5.2.2 Cats
5.2.3 Horses
5.2.4 Other Companion Animals
5.3 Food-Producing Animals
5.3.1 Poultry
5.3.2 Cattle
5.3.3 Pigs (Swine)
5.3.4 Sheep & Goats
5.3.5 Other Food-Producing Animals

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Italy
6.3.3 Spain
6.3.4 France
6.3.5 Germany
6.3.6 Rest Of Europe
6.4 Asia-Pacific
6.4.1 China
6.4.2 Japan
6.4.3 India
6.4.4 Rest Of Apac
6.5 Rest Of The World
6.5.1 Latin America
6.5.2 Middle East And Africa

7 Competitive Landscape
7.1 Introduction
7.2 Acquisitions
7.3 Agreements
7.4 New Product Launches
7.5 Expansions
7.6 Others

8 Company Profiles
8.1 Bayer Ag
8.1.1 Business Overview
8.1.2 Products
8.1.3 Key Financials
8.1.4 Growth Strategy
8.1.5 Recent Developments
8.1.6 Swot Analysis
8.1.7 Mnm View
8.2 Boehringer Ingelheim
8.2.1 Business Overview
8.2.2 Products
8.2.3 Key Financials
8.2.4 Growth Strategy
8.2.5 Recent Developments
8.3 Ceva Sante Animale
8.3.1 Business Overview
8.3.2 Products
8.3.3 Key Financials
8.3.4 Growth Strategy
8.3.5 Recent Developments
8.4 Eli Lilly And Company
8.4.1 Business Overview
8.4.2 Products
8.4.3 Key Financials
8.4.4 Growth Strategy
8.4.5 Recent Developments
8.4.6 Swot Analysis
8.4.7 Mnm View
8.5 Merck & Co., Inc.
8.5.1 Business Overview
8.5.2 Products
8.5.3 Key Financials
8.5.4 Growth Strategy
8.5.5 Recent Developments
8.5.6 Swot Analysis
8.5.7 Mnm View
8.6 Novartis Ag
8.6.1 Business Overview
8.6.2 Products
8.6.3 Key Financials
8.6.4 Growth Strategy
8.6.5 Recent Developments
8.6.6 Swot Analysis
8.6.7 Mnm View
8.7 Sanofi
8.7.1 Business Overview
8.7.2 Products
8.7.3 Key Financials
8.7.4 Growth Strategy
8.7.5 Recent Developments
8.7.6 Swot Analysis
8.7.7 Mnm View
8.8 Vetoquinol
8.8.1 Business Overview
8.8.2 Products
8.8.3 Key Financials
8.8.4 Growth Strategy
8.8.5 Recent Developments
8.9 Virbac Sa
8.9.1 Business Overview
8.9.2 Products
8.9.3 Key Financials
8.9.4 Growth Strategy
8.9.5 Recent Developments
8.10 Zoetis, Inc.
8.10.1 Business Overview
8.10.2 Products
8.10.3 Key Financials
8.10.4 Growth Strategy
8.10.5 Recent Developments
8.10.6 Swot Analysis
8.10.7 Mnm View

Appendix

List Of Tables

Table 1 Global Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 2 Global Animal Parasiticides Market, By Geography, 2011-2018 ($Million)
Table 3 Global Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 4 Global Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 5 Global Feed Additive Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 6 Global Injectables Animal Endoparasiticides Market, By Georgaphy, 2011-2018 ($Million)
Table 7 Global Oral Liquids Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 8 Global Oral Solids Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 9 Global Other Animal Endoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 10 Global Animal Ectoparasiticides Market, By Product Type, 2011-2018 ($Million)
Table 11 Global Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 12 Global Dips Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 13 Global Sprays Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 14 Global Pour-On And Spot-On Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 15 Global Collars Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 16 Global Ear Tags Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 17 Global Other Animal Ectoparasiticides Market, By Geography, 2011-2018 ($Million)
Table 18 Global Animal Endectocides Market, By Geography, 2011-2018 ($Million)
Table 19 Global Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 20 Global Parasiticides Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 21 Global Parasiticides Market For Companion Animals, By Country, 2011-2018 ($Million)
Table 22 Global Parasiticides Market For Dogs, By Country, 2011-2018 ($Million) Table 23 Global Parasiticides Market For Cats, By Country, 2011-2018 ($Million)
Table 24 Global Parasiticides Market For Horses, By Country, 2011-2018 ($Million)
Table 25 Global Parasiticides Market For Other Companion Animals, By Country, 2011-2018 ($Million)
Table 26 Global Parasiticides Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 27 Global Parasiticides Market For Food-Producing Animals, By Country, 2011-2018 ($Million)
Table 28 Global Parasiticides Market For Poultry, By Country, 2011-2018 ($Million)
Table 29 Global Parasiticides Market For Cattle, By Country, 2011-2018 ($Million)
Table 30 Global Parasiticides Market For Pigs, By Country, 2011-2018 ($Million)
Table 31 Global Parasiticides Market For Sheep & Goats, By Country, 2011-2018 ($Million)
Table 32 Global Parasiticides Market For Other Food-Producing Animals,By Country, 2011-2018 ($Million)
Table 33 Global Animal Parasiticides Market, By Geography, 2011-2018 ($Million)
Table 34 North America: Animal Parasiticides Market, By Country, 2011-2018 ($Million)
Table 35 North America: Animal Parasiticides Market, By Type Of Products, 2011-2018 ($Million)
Table 36 North America: Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 37 North America: Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 38 North America: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 39 North America: Animal Parasiticides Market For Food Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 40 North America: Animal Parasiticides Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 41 U.S.: Animal Parasiticides Market, By Type Of Products, 2011-2018 ($Million)
Table 42 U.S.: Animal Parasiticides Market, By Type Of Ectoparasiticides, 2011-2018 ($Million)
Table 43 U.S.: Animal Parasiticides Market, By Type Of Endoparasiticides, 2011-2018 ($Million)
Table 44 U.S.: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 45 U.S.: Animal Parasiticides Market For Food Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 46 U.S.: Animal Parasiticides Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 47 Canada: Animal Parasiticides Market, By Type Of Products, 2011-2018 ($Million)
Table 48 Canada: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 49 Canada: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 50 Canada: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 51 Canada: Market For Food Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 52 Canada: Market For Companion Animals,By Type Of Animal, 2011-2018 ($Million)
Table 53 Europe: Animal Parasiticides Market, By Country, 2011-2018 ($Million)
Table 54 Europe: Market, By Product Type, 2011-2018 ($Million)
Table 55 Europe: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 56 Europe: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 57 Europe: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 58 Europe: Veterinary Parasiticides Market, By Type Of Food Producing Animal, 2011-2018 ($Million)
Table 59 Europe: Animal Parasiticides Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 60 U.K.: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 61 U.K.: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 62 U.K.: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 63 U.K.: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 64 U.K.: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 65 U.K.:Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 66 Italy: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 67 Italy: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 68 Italy: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 69 Italy: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 70 Italy: Veterinary Parasiticides Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 71 Italy: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 72 Spain: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 73 Spain: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 74 Spain: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 75 Spain: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 76 Spain: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 77 Spain: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 78 France: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 79 France: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 80 France: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 81 France: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 82 France: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 83 France: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 84 Germany: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 85 Germany: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 86 Germany: Animal Endoparasiticides Market, By Product Type, 2011-2018 ($Million)
Table 87 Germany: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 88 Germany: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 89 Germany: Animal Parasiticides Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 90 Rest Of Europe: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 91 Rest Of Europe: Animal Ectoparasiticides Market, By Product Type, 2011-2018 ($Million)
Table 92 Rest Of Europe: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 93 Rest Of Europe: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 94 Rest Of Europe: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 95 Rest Of Europe: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 96 Apac: Animal Parasiticides Market, By Country, 2011-2018 ($Million)
Table 97 Apac: Market, By Type Of Product, 2011-2018 ($Million)
Table 98 Apac: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 99 Apac: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 100 Apac: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 101 Apac: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 102 Apac: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 103 China: Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 104 China: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 105 China: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 106 China: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 107 China: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million))
Table 108 China: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 109 Japan : Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 110 Japan : Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 111 Japan : Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 112 Japan: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 113 Japan: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 114 Japan: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 115 India: Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 116 India: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 117 India: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 118 India: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 119 India: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 120 India: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 121 Rest Of Apac: Animal Parasiticides Market, By Type Of Product, 2011-2018 ($Million)
Table 122 Rest Of Apac: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 123 Rest Of Apac: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 124 Rest Of Apac: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 125 Rest Of Apac: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
Table 126 Rest Of Apac: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
Table 127 Rest Of The World: Animal Parasiticides Market, By Region, 2011-2018 ($Million)
Table 128 Rest Of The World: Veterinary Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 129 Rest Of The World: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 130 Rest Of The World: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 131 Rest Of The World: Veterinary Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 132 Rest Of The World: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 133 Rest Of The World: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 134 Latin America: Animal Parasiticides Market,By Product Type, 2011-2018 ($Million)
Table 135 Latin America: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 136 Latin America: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 137 Latin America: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 138 Latin America: Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 139 Latin America: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 140 Middle East And Africa: Animal Parasiticides Market, By Product Type, 2011-2018 ($Million)
Table 141 Middle East And Africa: Animal Ectoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 142 Middle East And Africa: Animal Endoparasiticides Market, By Type Of Formulation, 2011-2018 ($Million)
Table 143 Middle East And Africa: Animal Parasiticides Market, By Type Of Animal, 2011-2018 ($Million)
Table 144 Middle East And Africa: Animal Parasiticides Market, By Type Of Food Producing Animals, 2011-2018 ($Million)
Table 145 Middle East And Africa: Market, By Type Of Companion Animal, 2011-2018 ($Million)
Table 146 Key Growth Strategies, 2011 - 2014
Table 147 Mergers & Acquisition, 2012-2014
Table 148 Agreements, 2012-2014
Table 149 New Product Launches, 2012-2014
Table 150 Expansions, 2011-2013
Table 151 Other Developments, 2013-2014

List Of Figures

Figure 1 Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 3 Data Triangulation Methodology
Figure 4 Global Animal Parasiticides Market, By Product Type ($Million)
Figure 5 Global Animal Parasiticides Market, By Animal Type ($Million)
Figure 6 High-Growth Markets, 2013
Figure 7 Market Segmentation
Figure 8 Global Animal Parasiticides Market Dynamics
Figure 9 Global Animal Parasiticides Market Share Analysis, 2013
Figure 10 Key Growth Strategies, 2011-2014
Figure 11 Bayer Ag: Revenue Segmentation, 2013
Figure 12 Bayer Consumer Health: Total Revenue ($Million), 2011-2013
Figure 13 Bayer Consumer Health: Revenue, By Business, 2013
Figure 14 Bayer Consumer Health: Revenue, By Geography, 2013
Figure 15 Boehringer Ingelheim: Total Revenue ($Million), 2011-2013
Figure 16 Boehringer Ingelheim: Revenue, By Business, 2012
Figure 17 Boehringer Ingelheim: Animal Health Business Revenue, By Geography, 2012
Figure 18 Ceva Sante Animale: Total Revenue ($Million), 2010-2012
Figure 19 Ceva Sante Animale: Revenue, By Geography, 2012
Figure 20 Eli Lilly And Company: Animal Health Business (Elanco)Revenue ($Million), 2011-2013
Figure 21 Eli Lilly And Company: Revenue, By Business, 2013
Figure 22 Elanco: Revenue, By Geography, 2013
Figure 23 Merck & Co., Inc.: Total Revenue ($Million), 2011-2013
Figure 24 Merck And Co., Inc.: Revenue, By Business, 2013
Figure 25 Merck And Co., Inc.: Revenue, By Geography, 2013
Figure 26 Novartis Ag: Revenue Segmentation, 2013
Figure 27 Novartis Consumer Health: Total Revenue ($Million), 2011-2013
Figure 28 Novartis Ag: Revenue, By Business, 2013
Figure 29 Novartis Consumer Health: Revenue, By Geography, 2013
Figure 30 Sanofi: Revenue Segmentation, 2013
Figure 31 Merial: Total Revenue ($Million), 2011-2013
Figure 32 Merial: Revenue, By Business, 2013
Figure 33 Merial: Revenue, By Geography, 2013
Figure 34 Vetoquinol: Total Revenue ($Million),2011-2013
Figure 35 Vetoquinol: Business Revenue, By Geography, 2013
Figure 36 Virbac Sa: Total Revenue ($Million), 2010-2012
Figure 37 Virbac Sa: Revenue, By Business, 2012
Figure 38 Virbac: Business Revenue, By Geography, 2012
Figure 39 Zoetis, Inc.: Total Revenue ($Million), 2011-2013
Figure 40 Zoetis, Inc.: Revenue, By Business, 2013
Figure 41 Zoetis, Inc.: Revenue, By Geography, 2013

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • Kuwait Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 123
    BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014, and the prospects for consumption remain bright. While price harmonisation across the GCC is likely to have a significant impact on margins in the sector, implementation remains slow. Concern over fake generic drugs presents opportunities for the segment in the country, and has spurred partnership agreements with local distributors in the region. Healthcare spending will remain strained as the ......
  • Malaysia Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 145
    BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality and access to healthcare, as the government plans to expand and upgrade its hospital network. However, we have downgraded Malaysia's pharmaceutical sales forecast due to a slowdown in pharmaceutical trade in 2013. The country's slower economic growth in 2014, coupled with the fact that investment in the pharmaceuticals sector will take longer than expected to bring returns, are downside risks to our ......
  • Portugal Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: Faster-than-expected economic growth last quarter has led us to revise our healthcare and pharmaceutical forecasts slightly upwards. As forecast previously, BMI expects Portugal's healthcare market to return to growth in 2015, while pharmaceuticals will not return to growth until 2019. This is because while Portugal exited its bailout programme in May 2014 without the need for a new financial package, government austerity measures are likely to curb pharmaceutical reimbursement. Portug......
  • Qatar Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 106
    BMI View: Medicine prices are expected to decline shortly in Qatar amid the 'imminent' unification of medicine importation channels and the adoption of a new medicine pricing mechanism by the member countries of the Gulf Co-operation Council (GCC). The unified regional pharmaceutical pricing policy among GCC member states will reduce medicine prices in Qatar and improve its national drug accessibility, if implemented properly. Although the drug pricing controls can potentially negatively affect ......
  • South Africa Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 125
    BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market - boasting the largest medicines market on the continent and poised for high single-digit growth over the next decade. Headline Expenditure Projections ? Pharmaceuticals: ZAR34.01bn (USD3.52bn) in 2013 to ZAR37.53bn (USD3.51bn) in 2014; +10.3% in local currency terms and -0.5% in US dollar terms. Forecast broadly in line with Q114. ? Healthcare: ZAR301.49bn (USD31.24bn) in 2......
  • Sri Lanka Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 80
    BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notably Indian - investors in recent years, as economic growth has picked up and the government focused on improving the domestic pharmaceutical sector. We therefore expect that pharmaceutical and healthcare sector growth will outpace economic growth over the five-year forecast period. Improved relations with India, after the country abstained from voting on the UNHCR resolution, are likely to spur fu......
  • United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: The UAE is one of the more developed markets in the Middle East and has a strong existing healthcare infrastructure. As the UAE is aiming to introduce comprehensive health insurance throughout the country, allowing businesses to shoulder much of the cost of this expanded coverage, the government will gradually contribute less to the country's healthcare spending. Between 2013 and 2018, we expect private sector healthcare spending to outpace public. However, the public sector will remai......
  • Czech Republic Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 112
    BMI View: Pharmaceutical sales will decline further this year, following the release of poor sales data from the first quarter. Price declines throughout Europe and restructuring of the healthcare system will continue to impact demand within the Czech Republic. We also believe the new centre-left coalition government poses downside risk to our forecasts given its commitment to containing healthcare costs and improving access to medicines. Despite these concerns, our view is more optimistic over ......
  • Denmark Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 58
    BMI View: Like many other Western European countries, Denmark's expanding elderly population will ensure that demand for quality healthcare remains high and will be a key driving factor for its wellestablished, albeit relatively small, pharmaceutical market. The robust demand for healthcare services will see the Danish government continue to adapt strategies and cost-containment measures to manage increasing healthcare costs. Despite this, we believe the country's high per-capita drug expenditur......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs